Cell
Volume 138, Issue 4, 21 August 2009, Pages 660-672
Journal home page for Cell

Article
LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer

https://doi.org/10.1016/j.cell.2009.05.050Get rights and content
Under an Elsevier user license
open archive

Summary

Lysine-specific demethylase 1 (LSD1) exerts pathway-specific activity in animal development and has been linked to several high-risk cancers. Here, we report that LSD1 is an integral component of the Mi-2/nucleosome remodeling and deacetylase (NuRD) complex. Transcriptional target analysis revealed that the LSD1/NuRD complexes regulate several cellular signaling pathways including TGFβ1 signaling pathway that are critically involved in cell proliferation, survival, and epithelial-to-mesenchymal transition. We demonstrated that LSD1 inhibits the invasion of breast cancer cells in vitro and suppresses breast cancer metastatic potential in vivo. We found that LSD1 is downregulated in breast carcinomas and that its level of expression is negatively correlated with that of TGFβ1. Our data provide a molecular basis for the interplay of histone demethylation and deacetylation in chromatin remodeling. By enlisting LSD1, the NuRD complex expands its chromatin remodeling capacity to include ATPase, histone deacetylase, and histone demethylase.

PROTEINS
HUMDISEASE
SIGNALING

Cited by (0)